Product information
From Health Canada
Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.
Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.
Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.
- Natural Product Number (NPN):
- 80090601
- Market status:
- Not Marketed
- Licence Status:
- Active
- Brand name(s):
-
PrimeZyme Full Spectrum Digestive Enzyme
;
Health First PrimeZyme Digestive Enzyme - Licence holder:
- Health First Network
- Dosage Form:
- Capsule
- Recommended route of administration:
-
Oral
Sub population (Sub Pop.) | Quantity (Qty) | Frequency (Freq.) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sub Pop. | Age | Min. | Max. | UoM Footnote1 Age | Qty | Min. | Max. | UoM Qty | Freq. | Min. | Max. | UoM Freq. |
Adults | 19 | year(s) | 1.0 | capsule | 1 | day | ||||||
- Recommended use or purpose:
- Digestive aid. Digestive enzyme. Helps digest proteins. Helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains).
- Risk Information:
- Cautions and Warnings
- Consult a health care practitioner prior to use if you are pregnant, breastfeeding, have gastrointestinal lesion/ulcer or excess stomach acid, diabetes, are taking anticoagulant agents, anti-inflammatory agents, antibiotics, or are having surgery.
- Known Adverse Reactions
- Stop use if hypersensitivity/allergy, nausea, vomiting, diarrhea, headaches, heartburn, bloating occurs.
Medicinal ingredients | Quantity (Qty) | Extract | Potency |
---|---|---|---|
1-Carboxy-N,N,N-trimethylmethanaminium chloride |
50.0 milligrams
|
||
4-(1,3;1,4)-beta-D-Glucan 4-glucanohydrolase |
8.34 milligrams
120.0 FCC CU |
||
4-alpha-D-Glucan glucanohydrolase |
133.65 milligrams
5940.0 FCC alpha-amylase dextrinizing units |
||
Protease |
133.65 milligrams
14850.0 FCC hemoglobin units on the tyrosine basis |
||
Stem bromelain |
3.75 milligrams
33750.0 FCC papain units |
||
Triacylglycerol lipase |
23.76 milligrams
297.0 FCC LU |
||
alpha-D-Galactoside galactohydrolase |
50.0 milligrams
50.0 FCC alpha-galactosidase units |
||
beta-D-galactoside galactohydrolase |
75.0 milligrams
75.0 FCC acid lactase units |
- List of non-medicinal ingredients:
-
- Gelatin
- Magnesium stearate
- Microcrystalline cellulose
- Date of licensing:
- 2019-02-14
- Revised date of licence:
Application information
Related information
Contact us
For technical support or if you have general questions concerning the content of this database, please contact the Natural Health Products Directorate (NHPD).